Difficulty: Medium
Average Score: 70%
Practice
One advantage of gemfibrozil (Lopid) is that, in addition to lowering blood levels of most lipids, it raises the level of HDL cholesterol. This consideration is:
Correct answer
A
Rationale
In this scenario, the correct answer is A) TRUE. Gemfibrozil, also known as Lopid, is a fibric acid derivative commonly used to lower blood lipid levels. One advantage of gemfibrozil is that it not only decreases levels of most lipids but also increases HDL cholesterol levels. This is important because HDL cholesterol is known as "good" cholesterol as it helps remove LDL cholesterol (the "bad" cholesterol) from the arteries, reducing the risk of heart disease.
Option B) FALSE is incorrect because gemfibrozil does indeed raise HDL cholesterol levels, as stated above. Option C) None and Option D) All the above are also incorrect as they do not accurately reflect the specific advantage of gemfibrozil in relation to HDL cholesterol.
From an educational standpoint, understanding the effects of different medications on lipid profiles is crucial in pharmacology. Knowing that gemfibrozil can raise HDL cholesterol levels is important for healthcare providers when prescribing medications to manage lipid disorders and reduce cardiovascular risk in patients. This knowledge helps in making informed decisions to optimize patient outcomes and prevent complications related to dyslipidemia.
Option B) FALSE is incorrect because gemfibrozil does indeed raise HDL cholesterol levels, as stated above. Option C) None and Option D) All the above are also incorrect as they do not accurately reflect the specific advantage of gemfibrozil in relation to HDL cholesterol.
From an educational standpoint, understanding the effects of different medications on lipid profiles is crucial in pharmacology. Knowing that gemfibrozil can raise HDL cholesterol levels is important for healthcare providers when prescribing medications to manage lipid disorders and reduce cardiovascular risk in patients. This knowledge helps in making informed decisions to optimize patient outcomes and prevent complications related to dyslipidemia.